Lymphocyte to Monocyte Ratio Based Nomogram for Predicting Outcomes of Hepatocellular Carcinoma Treated with Sorafenib

BACKGROUND: The ability of the pretreatment lymphocyte to monocyte ratio (LMR) to predict outcomes of patients with hepatocellular carcinoma (HCC) receiving sorafenib is not conclusively determined. METHODS: We retrospectively studied patients treated with sorafenib for HCC in two tertiary referral...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatol Int
Autors principals: Ha, Yeonjung, Ali, Mohamed A. Mohamed, Petersen, Molly M., Harmsen, William S., Therneau, Terry M., Lee, Han Chu, Ryoo, Baek-Yeol, Bampoh, Sally, Valles, Kenneth A., Mady, Mohamad, Missula, Venkata R., Prasai, Kritika, Roberts, Lewis R., Kim, Kang Mo
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8080900/
https://ncbi.nlm.nih.gov/pubmed/32740886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-020-10076-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars